Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. / Goodin, Douglas; Reder, Anthony; Traboulsee, Anthony; Li, David; Langdon, Dawn; Cutter, Gary; Cook, Stuart ; O'Donnell, Timothy; Kremenchutzky, Marcelo; Oger, Joel; Koelbach, Ralf; Pohl, Christoph; Wicklein, Eva-Maria.
In: Multiple Sclerosis, Vol. 25, No. 6, 01.05.2019, p. 837-847.Research output: Contribution to journal › Article › peer-review
Published
Documents
- Accepted Manuscript
Accepted author manuscript, 491 KB, Word document
| Original language | English |
|---|---|
| Pages (from-to) | 837-847 |
| Number of pages | 11 |
| Journal | Multiple Sclerosis |
| Volume | 25 |
| Issue number | 6 |
| Early online date | 15 May 2018 |
| DOIs | |
| Publication status | Published - 1 May 2019 |
This open access research output is licenced under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
ID: 29849677